Omnicell (OMCL)
(Delayed Data from NSDQ)
$29.31 USD
+0.02 (0.07%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $29.55 +0.24 (0.82%) 7:58 PM ET
4-Sell of 5 4
B Value D Growth F Momentum C VGM
Industry / Sector Report
Industry : Medical Info Systems
Zacks Industry Rank
Top 35% (89 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.50 | 1.72 | 9.99 |
Current Quarter Estimate | 0.16 | -0.31 | 61.00 |
Year Ago Quarter Estimate | 0.57 | 0.01 | 54.84 |
Next Quarter Estimate | 0.40 | -0.11 | 63.00 |
Next Year Estimate | 1.35 | 0.11 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -43.46 | 14.90 | 15.67 |
Next Year | 25.00 | 29.40 | 9.31 |
Last 5 Years | -6.10 | -10.70 | 8.10 |
Next 5 Years | 1.40 | 21.60 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 18.91 | -19.27 |
Price/Book (MRQ) | 1.13 | 1.34 |
Price/Cash Flow (MRFY) | 9.32 | 6.72 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -1.91% | -58.85% |
Return on Equity (TTM) | 2.41% | -41.29% |
Debt to Equity (MRQ) | NA | 20.74 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.